Cargando…

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine

Pharmacometabolomics (PMx) studies use information contained in metabolic profiles (or metabolome) to inform about how a subject will respond to drug treatment. Genome, gut microbiome, sex, nutrition, age, stress, health status, and other factors can impact the metabolic profile of an individual. So...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beger, Richard D., Schmidt, Michael A, Kaddurah-Daouk, Rima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241083/ https://www.ncbi.nlm.nih.gov/pubmed/32230776 http://dx.doi.org/10.3390/metabo10040129

Ejemplares similares

Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate
por: Kaddurah‐Daouk, Rima, et al.
Publicado: (2018)

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
por: Wikoff, William R., et al.
Publicado: (2013)

Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
por: Perroud, Bertrand, et al.
Publicado: (2013)

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
por: Vignoli, Alessia, et al.
Publicado: (2023)

Pharmacometabolomics Informs Viromics toward Precision Medicine
por: Balasopoulou, Angeliki, et al.
Publicado: (2016)

Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed-Pharmacogenomics
por: Yerges-Armstrong, Laura M., et al.
Publicado: (2013)

Oxylipid Profile of Low‐Dose Aspirin Exposure: A Pharmacometabolomics Study
por: Ellero‐Simatos, Sandrine, et al.
Publicado: (2015)

Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
por: Kaddurah-Daouk, R, et al.
Publicado: (2013)

Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
por: Zhu, Hongjie, et al.
Publicado: (2013)

Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability
por: Ellero-Simatos, S, et al.
Publicado: (2014)

Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers
por: Amaro, Filipa, et al.
Publicado: (2022)

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
por: Rotroff, DM, et al.
Publicado: (2015)

Metabolomics enables precision medicine: “A White Paper, Community Perspective”
por: Beger, Richard D., et al.
Publicado: (2016)

Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors
por: Cao, Zhijun, et al.
Publicado: (2019)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
por: Gupta, M, et al.
Publicado: (2016)

Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease
por: Katsila, Theodora, et al.
Publicado: (2016)

Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication
por: Jian, Jingai, et al.
Publicado: (2023)

Pharmacometabolomics by NMR in Oncology: A Systematic Review
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2021)

Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges
por: Gianazza, Erica, et al.
Publicado: (2023)

Pharmacometabolomics in Early‐Phase Clinical Development
por: Burt, T, et al.
Publicado: (2016)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
por: Vargas, Deninson Alejandro, et al.
Publicado: (2019)

Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
por: Geerts, Hugo, et al.
Publicado: (2019)

Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy
por: Kantae, Vasudev, et al.
Publicado: (2016)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
por: Amin, Arwa M., et al.
Publicado: (2017)

DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
por: Agapito, Giuseppe, et al.
Publicado: (2020)

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects
por: Nam, H W, et al.
Publicado: (2015)

Introduction to this Special Issue: “Biomarker Discovery and Precision Medicine”
por: Fang, Bingliang
Publicado: (2020)

Pharmacometabolomic Approach to Predict QT Prolongation in Guinea Pigs
por: Park, Jeonghyeon, et al.
Publicado: (2013)

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients
por: Corona, Giuseppe, et al.
Publicado: (2023)

Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer
por: Velenosi, Thomas J., et al.
Publicado: (2022)

Pharmacometabolomics of Bronchodilator Response in Asthma and the Role of Age-Metabolite Interactions
por: Kelly, Rachel S., et al.
Publicado: (2019)

Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
por: Zeng, Chang, et al.
Publicado: (2019)

Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
por: Wu, Xingyun, et al.
Publicado: (2023)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies
por: Searfoss, Richard, et al.
Publicado: (2022)

The Need for Multi-Omics Biomarker Signatures in Precision Medicine
por: Olivier, Michael, et al.
Publicado: (2019)

Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
por: Tan, Linyun, et al.
Publicado: (2023)

Deep learning facilitates multi-data type analysis and predictive biomarker discovery in cancer precision medicine
por: Mathema, Vivek Bhakta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_najo8shbibuia3co85gemlhb9n